In direct ELISAs, less than 1% cross-reactivity with recombinant human CILP-1 C-terminal peptide is observed. Reconstitute at 0.2 mg/mL in sterile PBS. Major alterations in the composition of the cartilage extracellular matrix occur in joint disease, suc